Efficacy of Probiotic VITA-PB2 from Fermented Foods on Alcohol Consumption and Hangover Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial

Chaodeng Mo, Johny Bajgai, Md Habibur Rahman, Sofian Abdul-Nasir, Ma Hui, Thu Thao Pham, Haiyang Zhang, Bingzhen Cao, Seong Hoon Goh, Bomi Kim, Hongik Kim, Min Kyeong Seol, Yan Yu, Cheol-Su Kim, Kyu‐Jae Lee, Seungtaek LimNutrients 2025 · DOI

TL;DR

This study investigated the efficacy of the probiotic Leuconostoc mesenteroides VITA-PB2 in mitigating alcohol-induced hangover symptoms and improving alcohol metabolism. VITA-PB2 supplementation demonstrated a significant reduction in acetaldehyde levels, enhanced aldehyde dehydrogenase (ALDH) activity, and attenuated oxidative stress markers, leading to improved subjective hangover experiences, particularly thirst.

What Problem Does This Paper Address?

Alcohol consumption is a widespread issue with significant economic and health consequences, including hangovers. Hangovers are characterized by a range of unpleasant physiological and psychological symptoms, stemming from complex mechanisms like acetaldehyde toxicity, oxidative stress, and gut dysbiosis. While strategies to mitigate these effects are sought, modulating ethanol metabolism and reducing oxidative stress are key therapeutic targets. This paper addresses the need for effective, safe interventions by evaluating a specific probiotic strain, Leuconostoc mesenteroides VITA-PB2, known for its potential to metabolize ethanol and its antioxidant properties, in a controlled human trial.

Methods

The researchers conducted a randomized, double-blind, placebo-controlled crossover study involving 28 healthy adults. Participants received either VITA-PB2 or a placebo before consuming a standardized amount of alcohol. After a 7-day washout period, they crossed over to the other treatment. Key measurements included:

  • Primary Outcomes: Blood ethanol and acetaldehyde levels, and aldehyde dehydrogenase (ALDH) activity.
  • Secondary Outcomes: Hangover severity (using the Acute Hangover Scale - AHS), liver enzymes (AST, ALT, GGT), oxidative stress indicators (ROS, NO), and antioxidant responses (GPx, catalase, DPPH scavenging capacity).

Blood samples were collected at various time points post-alcohol consumption for biochemical analyses. Subjective hangover symptoms were assessed using the AHS.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Targeted Metabolic Enhancement: VITA-PB2 appears to actively support the body's natural processes for breaking down alcohol and its toxic byproducts, rather than just masking symptoms.
  • Dual Action on Alcohol Metabolism: The probiotic not only seems to help clear ethanol more efficiently but also significantly reduces the buildup of acetaldehyde, a key culprit in hangover severity.
  • Oxidative Stress Mitigation: The study provides evidence that VITA-PB2 can actively combat the oxidative damage caused by alcohol, potentially offering a protective effect at the cellular level.
  • Subjective Symptom Relief: Beyond biochemical markers, the probiotic demonstrably improved how participants felt, particularly reducing the unpleasant sensation of thirst.
  • Safety Profile: The lack of reported adverse effects is crucial for any potential therapeutic intervention.

Key Results

  • Ethanol Clearance: VITA-PB2 supplementation led to a sustained reduction in blood ethanol concentrations from 0.5 hours post-ingestion compared to placebo.
  • Acetaldehyde Reduction: A significant reduction in blood acetaldehyde levels was observed at 1 hour post-ingestion in the VITA-PB2 group (32.68% decrease).
  • ALDH Activity Boost: VITA-PB2 significantly increased ALDH activity by 42.15% at 30 minutes post-alcohol consumption.
  • Oxidative Stress Reduction: ROS levels were markedly reduced at 1 hour post-ingestion in the VITA-PB2 group (p=0.02).
  • Antioxidant Enhancement: GPx activity was significantly enhanced at 2 hours post-ingestion in the VITA-PB2 group (p=0.002).
  • Hangover Symptom Improvement: The mean total AHS score was significantly lower in the VITA-PB2 group, with a notable and significant reduction in the symptom of "thirst" (p=0.048).

Limitations and Future Work

The authors acknowledge several limitations:

  • Small Sample Size: The study involved 28 participants, which may limit the generalizability of the findings.
  • Short Intervention Period: The trial duration was relatively short, and long-term effects and safety remain to be investigated.
  • Genetic Variability: Individual responses to alcohol are influenced by genetic polymorphisms (e.g., in ALDH2 and ADH1B enzymes). Future studies could stratify participants by genotype for more personalized insights.

Future research directions suggested include:

  • Longer-term Studies: To assess sustained effects on alcohol metabolism and physiological parameters.
  • Genotype-Stratified Analysis: To understand how genetic variations impact VITA-PB2 efficacy.
  • Synergistic Effects: Investigating the combined effects of VITA-PB2 with other probiotics or prebiotics for a broader microbiome-targeted strategy.

Summary updated

Abstract

<b>Background</b>: Modulating ethanol metabolism and attenuating alcohol-induced oxidative stress are promising therapeutic strategies for reducing the severity of hangovers and alleviating their associated physiological burden. <b>Methods</b>: A randomized, double-blind, placebo-controlled, crossover study was conducted to evaluate the effects of the probiotic strain <i>Leuconostoc mesenteroides</i> VITA-PB2 on ethanol metabolism, oxidative stress, and hangover-related symptoms in 28 healthy adults. The participants consumed either VITA-PB2 or a placebo before standardized alcohol intake, with a 7-day washout period and subsequent crossover. Primary outcomes included blood ethanol, acetaldehyde levels, and aldehyde dehydrogenase (ALDH) activity. Secondary outcomes measured hangover severity assessed by the Acute Hangover Scale (AHS), liver enzymes including aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyl transferase (GGT), oxidative stress indicators reactive oxygen species (ROS) and nitric oxide (NO), and antioxidant responses measured by glutathione peroxidase (GPx), catalase, and 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging capacity. <b>Results</b>: VITA-PB2 supplementation led to a sustained reduction in blood ethanol concentrations beginning at 0.5 h post-ingestion compared with the placebo group, indicating more efficient ethanol clearance. Additionally, VITA-PB2 significantly reduced acetaldehyde levels at 1 h post-ingestion (<i>p</i> < 0.05) and increased ALDH activity by 42.15% at 30 min (<i>p</i> < 0.05). It also markedly reduced ROS levels at 1 h (<i>p</i> < 0.05), enhanced glutathione peroxidase (GPx) activity at 2 h (<i>p</i> < 0.01), and significantly improved the subjective hangover symptoms, particularly thirst (<i>p</i> < 0.05). <b>Conclusions</b>: No adverse effects were reported during the trial, indicating that <i>Leuconostoc mesenteroides</i> VITA-PB2 is a safe probiotic. These findings suggest its efficacy in mitigating alcohol-induced oxidative stress and alleviating hangover-related symptoms.
BibTeX
@inproceedings{mo2025efficacy,
  author = {Chaodeng Mo and Johny Bajgai and Md Habibur Rahman and Sofian Abdul-Nasir and Ma Hui and Thu Thao Pham and Haiyang Zhang and Bingzhen Cao and Seong Hoon Goh and Bomi Kim and Hongik Kim and Min Kyeong Seol and Yan Yu and Cheol-Su Kim and Kyu‐Jae Lee and Seungtaek Lim},
  title = {{Efficacy of Probiotic VITA-PB2 from Fermented Foods on Alcohol Consumption and Hangover Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial}},
  booktitle = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17142276},
}
Figure